DJIA constituent returns (column 4 for 2018 full year returns)
Source: Refinitiv/Eikon
Merck, Pfizer led DJIA in tough 2018, Goldman, IBM lag
Skip to content
Essential thoughts on US stocks, financial markets, M&A and IPOs…and some other random topics